DrugsControl Media Services

News Detail

Lupin to sell trade generics business in India to Lupin Life Sciences for ₹100-120 crore (26-03-2024)

Mumbai, 26 March 2024: Pharma major Lupin Ltd on Friday (March 22) said the company is planning to carve out its trade generics business in India and transfer it to Lupin Life Sciences Ltd (LLSL), a wholly-owned subsidiary of the company, for ₹100-120 crore.


View Details
Source : CNBC-TV18
Lupin Life Sciences Lupin BSE share price today Lupin shares Lupin stock price Lupin share price India trade generics business Business Transfer Agreement Lupin slump sale

Related News